Clinical trials
Dermatitis, Atopic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,507 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 5 |
| 2002 | 7 |
| 2003 | 9 |
| 2004 | 31 |
| 2005 | 27 |
| 2006 | 19 |
| 2007 | 22 |
| 2008 | 27 |
| 2009 | 47 |
| 2010 | 32 |
| 2011 | 40 |
| 2012 | 33 |
| 2013 | 41 |
| 2014 | 46 |
| 2015 | 54 |
| 2016 | 53 |
| 2017 | 62 |
| 2018 | 95 |
| 2019 | 100 |
| 2020 | 85 |
| 2021 | 105 |
| 2022 | 111 |
| 2023 | 122 |
| 2024 | 104 |
| 2025 | 116 |
| 2026 | 93 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 933 |
| Recruiting | 152 |
| Unknown status | 128 |
| Terminated | 106 |
| Active, not recruiting | 67 |
| Not yet recruiting | 60 |
| Withdrawn | 46 |
| Enrolling by invitation | 11 |
| Available | 2 |
| Suspended | 1 |
| No longer available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 56 |
| LEO Pharma | 36 |
| Sanofi | 36 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 35 |
| AbbVie | 31 |
| Eli Lilly and Company | 29 |
| Regeneron Pharmaceuticals | 29 |
| Novartis Pharmaceuticals | 17 |
| Astellas Pharma Inc | 16 |
| Incyte Corporation | 16 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dermatitis, Atopic | 1,507 |
| Eczema | 324 |
| Dermatitis | 88 |
| Pruritus | 72 |
| Psoriasis | 72 |
| Skin Diseases | 55 |
| Asthma | 50 |
| Hypersensitivity | 40 |
| Food Hypersensitivity | 34 |
| Rhinitis, Allergic | 27 |
Trials
Showing 1 to 25 of 1,507. Each trial links to its page on Pharma Observatory.
1,407 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.